EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS074-01162 
Organism
Homo sapiens 
Tissue/cell
GM19239 
Coordinate
chr1:192574030-192575060 
Target genes
Number: 3             
NameEnsembl ID
TF binding sites/motifs
Number: 12             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ZNF263MA0528.1chr1:192574867-192574888GATGGAAGGAGGAAGGGAGGG+6.06
ZNF263MA0528.1chr1:192574879-192574900AAGGGAGGGAGGGGGAGAAAG+6.24
ZNF263MA0528.1chr1:192574889-192574910GGGGGAGAAAGAGAATGAGAG+6.36
ZNF263MA0528.1chr1:192574924-192574945GAGGGAGGGAGGAGGAGGGAG+6.74
ZNF263MA0528.1chr1:192574938-192574959GAGGGAGGGGGAAAGAGAGAA+6.75
ZNF263MA0528.1chr1:192574916-192574937AGAGGAGAGAGGGAGGGAGGA+7.27
ZNF263MA0528.1chr1:192574883-192574904GAGGGAGGGGGAGAAAGAGAA+7.46
ZNF263MA0528.1chr1:192574934-192574955GGAGGAGGGAGGGGGAAAGAG+7.92
ZNF263MA0528.1chr1:192574928-192574949GAGGGAGGAGGAGGGAGGGGG+8.12
ZNF263MA0528.1chr1:192574874-192574895GGAGGAAGGGAGGGAGGGGGA+8.37
ZNF263MA0528.1chr1:192574931-192574952GGAGGAGGAGGGAGGGGGAAA+8.94
ZNF263MA0528.1chr1:192574871-192574892GAAGGAGGAAGGGAGGGAGGG+9.25
Number of super-enhancer constituents: 6             
IDCoordinateTissue/cell
SE_43694chr1:192571742-192577024MM1S
SE_58423chr1:192573180-192611301Ly1
SE_59607chr1:192571834-192620763Ly4
SE_60433chr1:192573416-192610588DHL6
SE_61104chr1:192573010-192610405HBL1
SE_61454chr1:192540780-192610346Toledo
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr1192574180192574494
chr1192574140192574567
Number: 1             
IDChromosomeStartEnd
GH01I192605chr1192574180192574494
Enhancer Sequence
AAATGCTTTA CAAGTAATGT TTTACATAAA ATTTAATTAT TATGAATAAA TAGAACCTTT 60
AAAAACTAAA TCTTTCAAGA TTATATTCAT TCAAATGGAA ATAGCTAAAT TTGTGCATGA 120
ATATCAGATG ACTTCTTCCT GCCTTGGTTA CTAATGAATG GCCAAGCTTG TTTCTATAAA 180
TAAATGGGCA CTGGCATATT TTTTAAAAAA TACATGTGGC TCAAGATTAG ACTTCTTCCG 240
CTTTGTGGTA TCACATGTCT GACCACAGCA ACTATTTTAA ATCATGGTCT ATGCTTTTAA 300
TGACATCTAA CTCCACACAA AGAGTCATCA TTTTTATCTA GACGTGTGTG ACGTGCTTGA 360
TTGCAATGTG TTTTTTTTTT GTGTGTGTGT GTTGTTGTTT TTCTCTTTAT CATTTTAACA 420
TGCATTTCTA TAATACTTTG GTAATCTTGA AAACACTCAG GTCACCTTAC AACATCAAGA 480
CAGGCATAGA CCACTGTTTC CTTAAGTCTA TAAAGTTTTG TTATAAAAAT TGGGTAGCCA 540
GCTGTTCTTG GCCTAACATT AATCTAATAA AAGTGTTTCC AAAGAAAGTT TATGGAATGA 600
AAATTCATTG CTATTATTTT CAACTTTAAT TGAATTTTTA AATAAAAACA CTAAAAACTA 660
AACAATAGTA TTGAATACTA CTATTGGAAT TCATAGCTGG GCATGGCAGT GCATGCCTAT 720
AATCCCAGCT ACTCAGGATG CTGAGGCAGA AGGACTACTT GAGGCCAGAA GTTTGAGACT 780
AGCCTGAGCA ATATAGAAAA TCCTGTCTTA CATGAAATAC AGAAAGAAAG AGAGACAGAT 840
GGAAGGAGGA AGGGAGGGAG GGGGAGAAAG AGAATGAGAG AAAGAGAGAG GAGAGAGGGA 900
GGGAGGAGGA GGGAGGGGGA AAGAGAGAAA GAAAGAAAGA CAGAAAGAAA GAAAGACAGA 960
CAGACAGACA GACAGACAGA CAGAAAGAAA GAAAGAAAGA AAGAAAGAAA GAAAGAAAGA 1020
AAGAAAGAGG 1030